Omega Therapeutics, Inc. (OMGA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 162.57M |
| Enterprise Value | 222.56M |
| P/E Ratio | -0.08 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 2.55 |
| Price/Book Ratio | 0.13 |
| Enterprise/Revenue | 21.94 |
| Enterprise/EBITDA | -0.73 |
| Fiscal Year | December 31, 2023 |
| Most Recent Quarter | September 30, 2024 |
| Profit Margin | -31.49 |
| Operating Margin | -32.4 |
| Return On Assets | -0.48 |
| Return On Equity | -1.19 |
| Revenue | 3.09M |
| Revenue/Share | 0.06 |
| Gross Profit | -62.78M |
| EBITDA | -93.49M |
| Net Income | -97.43M |
| Diluted EPS | -1.8 |
| Total Cash | 30.38M |
| Total Cash/Share | 1.36 |
| Total Debt | 128.13M |
| Total Debt/Equity | 2.21 |
| Current Ratio | 3.35 |
| Book Value Per Share | 1.07 |
| 52-Week Change | -95.79 |
| 52-Week High | 4.44 |
| 52-Week Low | 0.03 |
| Moving Average 50 Days | 0.47 |
| Moving Average 200 Days | 1.21 |
| Average Volume | 9.59M |
| Shares Outstanding | 55.37M |
| % Held by Institutions | 85.72 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |